November 28, 2016 - By Peter Erickson
CRH Medical (TSE:CRH) had its target boosted by RBC Capital Markets to $8.50 in analysts note shared with investors on Monday, 28 November. The firm at present has a “Outperform” rating on the stock. The old price was $7.00.
About 1.37 million shares traded hands or 179.73% up from the average. CRH Medical Corp (TSE:CRH) has risen 104.40% since April 22, 2016 and is uptrending. It has outperformed by 98.39% the S&P500.
Insitutional Activity: The institutional sentiment decreased to 1.32 in 2016 Q2. Its down 0.53, from 1.85 in 2016Q1. The ratio is negative, as 17 funds sold all CRH Medical Corp shares owned while 23 reduced positions. 29 funds bought stakes while 45 increased positions. They now own 58.89 million shares or 151.35% more from 23.43 million shares in 2016Q1.
Moreover, Fincl Bank Of Ny Mellon Corporation has 0% invested in CRH Medical Corp (TSE:CRH) for 455,213 shares. Kayne Anderson Rudnick Investment Mgmt Limited Liability Co, a California-based fund reported 142,904 shares. Brandes Invest Prns L P holds 0.89% or 1.98 million shares in its portfolio. Estabrook Mngmt has 0% invested in the company for 19 shares. Moreover, Citigroup Inc has 0.01% invested in CRH Medical Corp (TSE:CRH) for 195,222 shares. Checchi Advisers reported 4,213 shares or 0.01% of all its holdings. Signaturefd Ltd Co has invested 0.01% of its portfolio in CRH Medical Corp (TSE:CRH). Springbok Limited Liability Corporation last reported 200 shares in the company. The Massachusetts-based Bollard Gru Ltd has invested 0.11% in CRH Medical Corp (TSE:CRH). Moreover, Utd Ser Automobile Association has 0.13% invested in CRH Medical Corp (TSE:CRH) for 1.27M shares. Bancorporation Of America Corp De has 0% invested in the company for 198,569 shares. Smithfield, a Pennsylvania-based fund reported 2,055 shares. Invesco holds 17,658 shares or 0% of its portfolio. Reilly Fin Ltd Llc has invested 0% of its portfolio in CRH Medical Corp (TSE:CRH). Comerica Comml Bank owns 70,126 shares or 0.02% of their US portfolio.
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare services and products company. The company has a market cap of $525.18 million. The Firm operates through divisions, including the sale of medical products and the provision of anesthesia services. It has a 54.96 P/E ratio. The Firm specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
According to Zacks Investment Research, “CRH plc manufactures cement, concrete products, aggregates, roofing, instulation and other building materials. Through its subsidiaries, the Company operates in Ireland, the United States, the United Kingdom, Spain, Germany and the Netherlands.”
CRH plc, incorporated on June 20, 1949, is a building materials company. The Firm makes and distributes a range of products servicing the construction needs, from the fundamentals of heavy materials and elements to construct the frame, through exterior products that complete the building envelope, to distribution channels, which service construction fit-out and renewal. The Firm operates in six divisions: Europe Heavyside, Europe Lightside, Europe Distribution, Americas Materials, Americas Products and Americas Distribution. The Firm operates in approximately 30 countries around the world.
More news for CRH Medical Corp (TSE:CRH) were recently published by: Quotes.Wsj.com, which released: “News CRH Medical Corp.CRHM” on September 04, 2015. Marketwatch.com‘s article titled: “CRH Medical Corp.” and published on September 10, 2015 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.